OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ubiquitin Ligases in Cancer Immunotherapy – Balancing Antitumor and Autoimmunity
Yu Fujita, Roberto Tinoco, Yan Li, et al.
Trends in Molecular Medicine (2019) Vol. 25, Iss. 5, pp. 428-443
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Advancing to the era of cancer immunotherapy
Yun Wang, Min Wang, Hao‐Xiang Wu, et al.
Cancer Communications (2021) Vol. 41, Iss. 9, pp. 803-829
Open Access | Times Cited: 132

E1 Enzymes as Therapeutic Targets in Cancer
Samir H. Barghout, Aaron D. Schimmer
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 1-56
Open Access | Times Cited: 81

Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways
Jiaxin Liu, Yicheng Cheng, Ming Zheng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 57

Regulatory Mechanisms of Inhibitory Immune Checkpoint Receptors Expression
Nicolas Curdy, Olivia Lanvin, Camille Laurent, et al.
Trends in Cell Biology (2019) Vol. 29, Iss. 10, pp. 777-790
Open Access | Times Cited: 59

Ubiquitin ligases in cancer: Functions and clinical potentials
Shanshan Duan, Michele Pagano
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 918-933
Open Access | Times Cited: 50

Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b
Miao Yu, Jie Li, Wenying Gao, et al.
Journal of Virology (2024) Vol. 98, Iss. 6
Open Access | Times Cited: 7

The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer
Xiaofeng Gong, Danyu Du, Yanran Deng, et al.
Investigational New Drugs (2020) Vol. 38, Iss. 2, pp. 515-524
Closed Access | Times Cited: 40

High-throughput matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry–based deubiquitylating enzyme assay for drug discovery
Virginia De Cesare, Jennifer L. Moran, Ryan Traynor, et al.
Nature Protocols (2020) Vol. 15, Iss. 12, pp. 4034-4057
Open Access | Times Cited: 40

Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy
Shubhangi Gavali, Jianing Liu, Xinyi Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10800-10800
Open Access | Times Cited: 37

CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9
Yuwei Zhang, Fengping Liu, Yangkun Feng, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 11, pp. 1731-1741
Open Access | Times Cited: 24

Ubiquitin proteasome system in immune regulation and therapeutics
Sameer Ahmed Bhat, Zahra Vasi, Ritika Adhikari, et al.
Current Opinion in Pharmacology (2022) Vol. 67, pp. 102310-102310
Open Access | Times Cited: 23

SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis
Xiang Song, Xinzhao Wang, Xiqi Chen, et al.
Journal of Proteomics (2023) Vol. 292, pp. 105055-105055
Closed Access | Times Cited: 14

A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features
Zihan Quan, Songqing Fan, Hongmei Zheng, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access

USP18 Confers Paclitaxel Resistance in Non‐Small Cell Lung Cancer by Stabilizing SHANK1 Expression Via Deubiquitination
Lixun Chai, Yanlong Sun, Yunfei Wang, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access

MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells
Wenjing Chen, Dhwani Patel, Yuzhi Jia, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2550-2550
Open Access | Times Cited: 22

A Plasmodium falciparum RING Finger E3 Ubiquitin Ligase Modifies the Roles of PfMDR1 and PfCRT in Parasite Drug Responses
Brajesh K. Singh, Cui Zhang, Jian Wu, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 2
Open Access | Times Cited: 7

Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in Pancreatic Cancer
Lei Feng, Jieqing Wang, Jianmin Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17

NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin–proteasome pathway
Rui Feng, Zhongxing Li, Guangcheng Ge, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 1, pp. 243-255
Closed Access | Times Cited: 12

POLE2 promotes osteosarcoma progression by enhancing the stability of CD44
Baichuan Wang, Hongzhi Hu, X.M. Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2

Extracellular vesicles and post-translational protein deimination signatures in haemolymph of the American lobster (Homarus americanus)
Timothy J. Bowden, Igor Kraev, Sigrun Lange
Fish & Shellfish Immunology (2020) Vol. 106, pp. 79-102
Closed Access | Times Cited: 17

SYVN1‐mediated ubiquitination and degradation of MSH3 promotes the apoptosis of lens epithelial cells
Xiaojuan Chen, Guowei Zhang, Pengfei Li, et al.
FEBS Journal (2022) Vol. 289, Iss. 18, pp. 5682-5696
Closed Access | Times Cited: 10

Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP
Qingting Wang, Wenhua Shi, Qianqian Zhang, et al.
Life Sciences (2019) Vol. 242, pp. 117159-117159
Closed Access | Times Cited: 17

Page 1 - Next Page

Scroll to top